Search

It is a recognition granted by Másfamilia Foundation that recognizes those entities that, from their structure and organization, contribute most to work and family life balance

The objective of this study was to evaluate the incidence of the disease at the hospital level and to calculate the associated medical costs

The biotechnology firm completes the seed round funding with a total of €6 million led last December by AdBio Partners, Invivo Capital and Takeda Ventures The Integra Therapeutics gene writing

On 28 April, AseBio Investor Day will bring together more than 50 investors from all over the world with disruptive biotech companies so they can meet and consolidate connections. We spoke with some

Extensive academic and industry experience in hematology/oncology Will coordinate Oryzon’s global clinical development from Boston, USA

Virtual Bio-Europe Spring 2022 Kempen Life Sciences Conference Asebio Investor Day

Sermes CRO, together with Mikrobiomik, manages the first submission of a clinical trial in Spain through CTIS (Clinical Trial Information System), the new European clinical trial’s portal

Spanish biotech Algenex announces its expansion into the food tech market. The Company’s patented CrisBio® production platform can deliver the essential biologics that form part of the “growth media”

Asphalion is enhancing its Corporate Social Responsibility programme with significant commitment to three of UN 2030 sustainable development goals

The results of the study, published in Nature Communications, open up a new path for research to design new, more effective therapeutic targets for this type of tumour, based on blocking the metabolic

Meet the Centre for Plant Biotechnology and Genomics (CBGP, UPM-INIA/CSIC), our new member. We spoke to Antonio Molina, director of the entity

In combination with gilteritinib Primary objectives: to assess safety, tolerability and RP2D Secondary objectives: to assess efficacy